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Suppressive drug interactions, in which one antibi-
otic can actually help bacterial cells to grow faster
in the presence of another, occur between protein
and DNA synthesis inhibitors. Here, we show that
this suppression results from nonoptimal regulation
of ribosomal genes in the presence of DNA stress.
Using GFP-tagged transcription reporters in Escher-
ichia coli, we find that ribosomal genes are not
directly regulated by DNA stress, leading to an imbal-
ance between cellular DNA and protein content. To
test whether ribosomal gene expression under DNA
stress is nonoptimal for growth rate, we sequentially
deleted up to six of the seven ribosomal RNA
operons. These syntheticmanipulations of ribosomal
gene expression correct the protein-DNA imbalance,
lead to improved survival and growth, and com-
pletely remove the suppressive drug interaction. A
simple mathematical model explains the nonoptimal
regulation of ribosomal genes under DNA stress as
a side effect of their optimal regulation in different
nutrient environments. These results reveal the
genetic mechanism underlying an important class
of suppressive drug interactions.
INTRODUCTION
Drug combinations can be an important tool for studying biolog-
ical systems and revealing relationships between different
cellular processes (Keith et al., 2005; Leha´r et al., 2008, 2007;
Tsui et al., 2004). The interaction between two drugs can be
classified as additive, synergistic, or antagonistic according to
their combined effect being equal, greater, or less than that ex-
pected based on their individual effects, Figure 1A (Bliss, 1939;
Loewe, 1928, 1953; Pillai et al., 2005). Much attention has been
given to synergistic drug combinations due to their increased
potency. Antagonism, however, may have an advantage in
slowing down and even reversing the evolution of resistance(Chait et al., 2007; Hegreness et al., 2008; Michel et al., 2008;
Yeh et al., 2006).
A particularly strong kind of antagonism, termed ‘‘suppres-
sion,’’ occurs when the combined inhibitory effect of two drugs
isnot onlyweaker than the expectedadditivesum,but alsoweaker
than the effect of one of the drugs alone (Figure 1A; Pillai et al.,
2005). We have previously reported that in the presence of a
DNA synthesis-inhibiting antibiotic, the addition of a protein
synthesis inhibitor increases the steady state growth rate of
Escherichia coli (Figure 1B) and Staphylococcus aureus (Chait
et al., 2007; Yeh et al., 2006). Many different pairings of DNA
synthesis and translation inhibitors show this suppressive drug
interaction (Yeh et al., 2006; see examples in Figures 1B and S1
available online), indicating that these interactions result from the
effect of the drugs on bacterial physiology rather than from direct
chemical interaction between the drugs. Considerable recent
work has advanced our understanding of the effects of individual
antibiotics on gene expression and cellular physiology (Brazas
and Hancock, 2005; Davies et al., 2006; Drlica et al., 2008; Fajardo
and Martinez, 2008; Goh et al., 2002; Hoffman et al., 2005; Kohan-
ski et al., 2007, 2008; Kolodkin-Gal et al., 2008; Linares et al., 2006;
Mason et al., 1995; Mesak et al., 2008; Piddock et al., 1990; Shaw
etal., 2003;Yim etal., 2006; Yim etal., 2007),but the effects ofdrug
combinations are less well understood and the mechanism that
underlies suppressive drug interactions remains unknown.
It has been argued that many aspects of bacterial physiology
have evolved to be ‘optimal’ - namely to maximize growth rate in
a given condition (Dekel and Alon, 2005; Ibarra et al., 2002;
Liebermeister et al., 2004). When protein synthesis inhibitors
are added to DNA synthesis inhibitors, however, the cells actu-
ally grow faster. Thus, the overall rate of protein synthesis under
DNA stress appears to be above the optimal value for maximum
growth. This overall rate of protein synthesis is primarily deter-
mined by the number of ribosomes per cell, which is known to
be tightly controlled (Gralla, 2005; Keener and Nomura, 1996;
Moss, 2004; Paul et al., 2004). Precise regulation of ribosome
synthesis is crucial for maximizing growth: under-production of
ribosomes causes ineffective use of cellular resources, while
over-production leads to an excess use of resources for protein
synthesis at the expense of other cellular processes (Gralla,
2005; Keener and Nomura, 1996; Levy et al., 2007; Paul et al.,
2004). As a result, in any particular environment, there existsCell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc. 707
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Figure 1. Suppression of DNA Synthesis Inhibitors by Translation Inhibitors Suggests the Hypothesis that Ribosomal Genes Are Not Opti-
mally Regulated under DNA Stress
(A) Minimal Inhibitory Concentration (MIC) lines in the two-dimensional concentration space of two drugs. Two drugs are defined to interact additively if their
combined effect is constant along linear lines of fixed total dosage (Loewe, 1928). Synergy and antagonism are defined as negative or positive deviations
from this null line. A particularly strong type of antagonism—suppression—characterizes drug pairs whose combined effect is weaker than that of one of the drugs
alone (magenta line).
(B) Suppressive interaction is seen in measurements of growth rates (gray levels) and MIC line (magenta) in a two-dimensional gradient of the translation inhibitor
spiramycin (SPR) and the DNA synthesis inhibitor trimethoprim (TMP, inhibitor of DNA synthesis through folic acid deficiency). In the absence of DNA synthesis
inhibitor (black line), growth rate is maximal without translation inhibition (black triangle) and reduces monotonically with the level of translation inhibitor. In
contrast, at fixed finite concentration of DNA synthesis inhibitor (red line), growth rate increases initially as the translation inhibitor concentration increases, reach-
ing a maximal value (red triangle) at intermediate translation inhibition level.
(C) Schematic expectation for growth rate as a function of ribosomal gene expression in absence (black line) or presence (red line) of an antibiotic. Arrows show
possible ribosomal gene expression regulation in response to antibiotic addition. The comparison of panels (B) and (C) suggests the hypothesis that a nonoptimal,
too high ribosome level in response to DNA synthesis inhibitors may cause this suppressive drug interaction. MICs for antibiotics are summarized in Table 1.an optimal level of ribosomes that maximizes the bacterial
growth rate (Figure 1C). The observation that, under DNA stress,
reduction in protein synthesis allows faster growth suggests that
ribosome level is not optimally regulated in these conditions.
The rate of ribosome synthesis in E. coli is determined by the
transcription rate of the ribosomal RNA operons (rrn operons;
Keener and Nomura, 1996; Paul et al., 2004), which code for the
three different ribosomal RNAs. Feedback mechanisms at the
level of translation adjust ribosomal protein synthesis to stoichio-
metrically match rRNA production (Keener and Nomura, 1996).
The standard E. coli lab strain K12 MG1655 has seven almost
identical copies of the rrn operons, which are among the most
highly transcribed loci in the genome. Multiple copies are needed
because the maximal transcription rate from a single rrnoperon is
insufficient for the ribosome synthesis required at high growth
rates (Condon et al., 1995; Stevenson and Schmidt, 2004).708 Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc.The rrn operons are regulated to achieve maximal growth in
different nutrient environments. The levels of factors that reflect
intracellular levels of resources such as amino acids and energy,
including nucleoside triphosphates (NTPs), guanosine penta-
phosphate and tetraphosphate (collectively referred to as
ppGpp), affect rrn transcription (Cashel et al., 1996; Dennis
et al., 2004; Gaal et al., 1997; Keener and Nomura, 1996; Paul
et al., 2004; Schneider et al., 2002; Schneider and Gourse,
2004). Overproduction of protein depletes these resources and
thus downregulates ribosome synthesis (Gralla, 2005; Paul
et al., 2004). In many environmental conditions, this negative
feedback loop is able to maintain ribosome concentration near
its optimal level (the level that maximizes growth rate); in partic-
ular, ribosome synthesis is kept high in nutrient-rich environ-
ments and is shut down as a consequence of nutrient starvation
(Cashel et al., 1996). However, it is unclear if the regulation of
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Figure 2. DNA Synthesis Inhibitors Lead to Increased Cell Size and Protein-DNA Ratio
(A) Microscopy images of DAPI stained (cyan) E. coli cells growing in absence of antibiotics (Ø) and in presence of translation inhibitor TET and DNA synthesis
inhibitors NAL and TMP. Scale bar, 10 mm. DNA synthesis inhibitors lead to a mixed population of cells that are larger and contain only one or few nucleoids (white
arrows). A small fraction of cells has no nucleoid (black arrows).
(B) Histograms of cell lengths. Mean cell size and variability increases in presence of DNA synthesis inhibitors but not in presence of translation inhibitors.
(C) Mean total protein per cell (measured by a variant of the Lowry assay) in presence of different antibiotics normalized to no drug control. All antibiotic concen-
trations are tuned to achieve the same normalized growth rate (0.35). See Experimental Procedures.ribosome synthesis leads to optimal expression levels (maximal
growth) under all stress conditions, and in particular under DNA
stress (Figure 1C).
The observation that, under DNA stress, inhibition of protein
synthesis actually increases the rate of cellular growth suggests
that the number of ribosomes per cell in these conditions is too
high. Overexpression of ribosomes under these conditions
would lead to an inefficient use of cellular resources and a growth
rate that is lower than could be maximally achieved. Here, we
test the hypothesis that the rate of ribosome synthesis in bacteria
is nonoptimal under DNA stress, and that this nonoptimality
causes the suppressive drug interactions in which translation
inhibitors allow faster growth under DNA synthesis inhibition.
We address this hypothesis by measuring cell composition,
morphology and gene expression changes in response to antibi-
otics, by genetically manipulating ribosome synthesis, and by
using a theoretical analysis of resource allocation in the cell.
RESULTS
Protein-DNA Ratio Is Skewed under DNA Stress
We first examined the changes in cell morphology and composi-
tion that result from treating cells with DNA synthesis inhibitors.
These inhibitors cause DNA damage and trigger the SOS
response, including expression of the cell division inhibitor sulA(Huisman and D’Ari, 1981; Mesak et al., 2008; Walker, 1996).
This prevents cell division before chromosome replication is
completed (Huisman and D’Ari, 1981), leading to an increased
average cell size (Walker, 1996) and cell size variability, in partic-
ular at sub-inhibitory antibiotic concentrations where exponen-
tial growth occurs at a reduced rate (Figure 2A,B). The increased
cell size under DNA stress correlates with an elevated average
amount of protein per cell (Figure 2C; measured by a modified
Lowry assay, Experimental Procedures). Cellular DNA, however,
is typically still restricted to only one or two nucleoids (Figure 2A)
and, with increasing concentration of DNA synthesis inhibitor,
the mean DNA content decreases per volume and even per cell
(Georgopapadakou and Bertasso, 1991). The ratio of protein
to DNA therefore significantly increases in the presence of
DNA synthesis inhibitors. We hypothesized that this imbalance
could be caused by excessive production of ribosomes in the
cell, leading to overproduction of proteins and thus to reduced
growth rates. We therefore examined whether and how ribo-
some synthesis is regulated in response to DNA synthesis
inhibitors.
Ribosomal Gene Expression Is Not Specifically
Regulated by DNA Stress
We used strains from a genome-wide GFP transcription reporter
library (Zaslaver et al., 2006, 2004) to measure changes in theCell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc. 709
expression level of promoters from almost 200 E. coli genes, rep-
resenting key cellular functions including DNA stress response,
metabolism and ribosome regulation and synthesis (Table S1).
We obtained high time resolution measurements of optical
density and GFP fluorescence of cultures growing in the pres-
ence of different antibiotics at a range of concentrations. We
focused on measurements during exponential growth phase
since our main interest in this work is to understand the combined
effects of drugs on steady state growth. Growth rates (g) were
determined from the increase in optical density over time (OD,
Figure 3A). Changes in gene expression level (g) were defined
as the effect of the drug on the average GFP signal per OD during
exponential phase (g= [GFP/OD] / [GFP/OD]no drug; Figure 3A and
Experimental Procedures). By repeating the measurement at
a range of drug concentrations, we determined expression level
changes in response to antibiotics as a function of growth
inhibition (see example for trimethoprim (TMP) in Figure 3B;
antibiotics used in this study are summarized in Table 1). As
expected, most SOS response genes were upregulated in
response to DNA stress caused by any of three different DNA
synthesis inhibitors (TMP, Figure 3B; ciprofloxacin [CPR] and
nalidixic acid [NAL], Figure S2). On the other hand, most ribo-
somal genes were downregulated in response to these DNA
synthesis inhibitors (Figures 3B, 3C, and S2). Consistent with
the downregulation of ribosomal genes, the ppGpp-regulated
ribosome inactivator gene rmf (Izutsu et al., 2001) was upregu-
lated in response to TMP (Figure 3B).
How much are ribosomal genes downregulated under DNA
synthesis stress? Ribosome production is normally reduced
when the growth rate of the cell is reduced (Bremer and Dennis,
1996), but it is possible that the inhibition of DNA synthesis may
also have a more specific effect on ribosome synthesis. To
distinguish between nonspecific (growth-mediated) and specific
effects of DNA synthesis inhibition on growth, we compared the
change in expression of ribosomal genes in the presence of anti-
biotics that inhibit DNA synthesis to the change seen when
growth rate is reduced using a poor growth medium. We found
that, for equivalent reductions in cellular growth rate caused by
these two mechanisms, the degree to which ribosomal gene
expression is downregulated is essentially identical (Figures 3C
and 3D). Thus, we see no evidence for specific regulation of ribo-
somal expression by DNA stress.
While DNA synthesis inhibitors did not specifically regulate
ribosome production, the translation inhibitors spiramycin
(SPR) and tetracycline (TET) elicit an upregulation of ribosomal
gene expression (Figure 3D) which counters the effect of
these drugs, consistent with previous studies (Fraenkel and
Neidhardt, 1961; Kurland and Maaløe, 1962; Schneider et al.,
2002). We next asked how this upregulation of ribosomal genes
in response to protein synthesis inhibitors is affected by the pres-
ence of DNA synthesis inhibitors. We measured the regulation
of 80 promoters including nine that control ribosomal genes
(Table S1) in a two-dimensional concentration matrix of TMP
and SPR (Experimental Procedures). For each promoter, we
obtained its fold change in expression level as a function of the
two drug dosages (Figures 4A and S3; Experimental Procedures;
Kaplan et al., 2008; Tsui et al., 2004). We found that ribosomal
gene expression levels in the presence of TMP are lower than710 Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc.in its absence for any SPR level (Figure 4A) and the upregulation
of ribosomal genes by SPR is significantly delayed (occurs at
higher SPR concentrations) under TMP stress (arrow in Fig-
ure 4B). Consequently, the increase in growth resulting from
the addition of a translation inhibitor in the presence of a DNA
synthesis inhibitor occurs without substantial increase in ribo-
some production.
This delayed response allows a translation inhibitor to
substantially reduce overall protein synthesis and restore the
protein-DNA ratio to near its normal value (Piddock et al.,
1990), plausibly explaining the ability of translation inhibitors to
increase the survival and growth of cells suffering DNA synthesis
inhibition. Hence, the results discussed so far are consistent with
the hypothesis that the ribosome synthesis rate is not optimally
controlled under prolonged DNA stress; that is, it is not suffi-
ciently downregulated to maximize cellular growth rate. But
how can we test this hypothesis more directly? The hallmark of
nonoptimality is the possibility for improvement: if cellular
production of ribosomes is indeed nonoptimal under DNA stress,
we should be able to manipulate it to increase cellular survival
and growth.
Manipulating Ribosome Synthesis Increases Growth
Rate and Survival in the Presence of DNA Synthesis
Inhibitors
To test whether direct manipulation of ribosome levels affects
growth and survival in the presence of DNA synthesis inhibitors,
we measured responses to antibiotics in strains that are engi-
neered to decrease or increase ribosome synthesis. Following
previous work (Asai et al., 1999; Condon et al., 1993), we con-
structed strains in which up to six of the seven rrn operons
were incrementally deleted (designated D1, D2, D3, D4, D5,
and D6; Experimental Procedures; Table S2; no plasmid-borne
rrn operons were added to these strains). Our construction
method removes the selection marker linked to each of the rrn
operon deletions, allowing a direct comparison of the physiology
of these strains with wild-type (Experimental Procedures). The
relationship between the number of rrn operons and ribosome
levels is not necessarily linear, since feedback regulation of
ribosome synthesis partially compensates for deletions by
increasing the expression of the remaining rrn operons (Condon
et al., 1993). Nevertheless, ribosome levels and the rRNA
concentration – an upper bound for ribosome level – is reduced
by deleting rrn operons, particularly in rich growth media where
rrn operon transcription rates are close to saturation and cannot
be increased much further (Asai et al., 1999; Condon et al., 1993).
We also examined strains deleted for the genes relA and spoT;
these double-deletion mutants are devoid of ppGpp, a key nega-
tive regulator of ribosome synthesis (Xiao et al., 1991), and thus
show increased rrn expression (Barker et al., 2001; Bartlett and
Gourse, 1994). The relA spoT deletion strain has a longer lag
time for the transition from stationary phase to exponential
growth and a slightly reduced steady state growth rate
(Figure S16; Gaal and Gourse, 1990).
We measured growth rates of these modified strains in normal
conditions as well as under conditions where different antibiotics
were added to the cultures. In the absence of antibiotics, the
wild-type strain grows faster than all mutants with altered
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Figure 3. Ribosomal Gene Expression Is Downregulated under DNA Stress Only as Much as in the Normal Physiological Response to Slow
Growth
(A) Example data demonstrating measurement of drug effect on growth rate and transcription reporters. Optical Density (OD) and GFP expression from various
promoters (shown, as an example, is the promoter of lexA – the master regulator of the SOS response) are measured as a function of time for various drug concen-
trations (shown, 0, 0.5 and 1mg/ml TMP). Top: growth rates are defined by linear regression (green lines) to the OD curves (black). Bottom: Expression levelg (green
lines) is defined as GFP fluorescence intensity per OD, averaged over an OD range of exponential growth (shaded region) and normalized to no drug control.
(B) Normalized expression levels 3x of 110 promoters in E. coli as a function of growth rate in various concentrations of TMP. For each promoter x, 3x is defined as
expression level gx, normalized to the median expression level of all promoters <g> (Experimental Procedures). SOS response promoters are upregulated (black
triangles). Most ribosomal promoters are downregulated (orange squares) consistent with the upregulation of the ribosome inactivator rmf (black crosses).
Random scatter added to growth rate to enhance visibility.
(C) Top: Cumulative distributions of normalized expression levels 3x showing downregulation of ribosomal genes (orange) relative to all other promoters (gray) at
a fixed concentration of TMP (normalized growth rate 0.49). Bottom: a similar regulation is seen with no drug when the same change in growth rate is achieved
by changing the carbon source from glucose to glycerol.
(D) Mean normalized expression level of ribosomal promoters 3ribos as a function of normalized growth rate for different DNA synthesis inhibitors (CPR, NAL, TMP;
red), translation inhibitors (SPR, TET; blue), and in growth media with different carbon sources (glucose, galactose, glycerol; gray). Inset: 3ribos values at normalized
growth rate of approximately 0.45 (panel [D], gray region); error bars show SEM. Ribosomal promoters are upregulated in response to translation inhibitors and
downregulated in presence of DNA synthesis inhibitors. This downregulation, however, is similar to the growth-rate dependent downregulation that results from
a change of carbon source (gray horizontal line).Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc. 711
ribosome synthesis; genetically increasing or decreasing ribo-
some synthesis leads to reduced growth rates (Figure 5A). This
observation confirms previous results (Asai et al., 1999) and is
in agreement with the idea that ribosomal synthesis is optimally
regulated to maximize growth in the absence of stress (Gralla,
2005; Paul et al., 2004).
In DNA stress conditions, however, the picture is profoundly
different (Figures 5A, S4A, and S4B). As expected, all strains
grow more slowly under DNA stress than in a stress-free environ-
ment (Figures 5A, CPR curve lower than no-drug curve). But, in
the presence of the DNA synthesis inhibitors CPR and NAL,
the strain with maximal growth is not the wild-type, but rather
a strain with reduced ribosome synthesis (D5 at the drug concen-
tration shown in Figures 5, S4A, and S4B). Complementing the
deletion strains with a plasmid expressing one of the rrn operons
(rrnB), partially revokes the increase in growth of these deletion
mutants under DNA stress, confirming that this phenotype is
Table 1. Antibiotics Used in This Study, Abbreviation, MIC in the
Wild-Type MG1655 Strain, and Main Mode of Action
Antibiotic Abbreviation
MIC in LB
(mg/ml)
MIC in M9
(mg/ml) Mode of action
Ciprofloxacin CPR 0.012 0.012 DNA gyrase
Nalidixic acid NAL 6 6 DNA gyrase
Trimethoprim TMP 0.42 1.5 Folic acid
synthesis
Spiramycin SPR 192 120 Protein
synthesis, 50S
Tetracycline TET 1.5 1.5 Protein
synthesis, 30S
Nitrofurantoin NIT 5 5 Multiple
mechanisms712 Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc.directly related to the reduction in rrn operons (Figure S13). Coin-
cident with their increased growth rate compared to wild-type,
the deletion stains also have a closer to normal cell size under
DNA synthesis inhibition (Figure S5). Thus, in the presence of
DNA synthesis inhibitors the expression of rrn genes in the
wild-type appears to be higher than optimal.
We next tested if optimizing ribosome synthesis also allows
cells to tolerate higher concentrations of DNA synthesis inhibi-
tors. We determined changes of the minimal inhibitory concen-
tration (MIC) in the rrn deletion mutants for a range of antibiotics
(Experimental Procedures). Indeed, as we delete rrn operons we
see an incremental increase in MIC for the DNA synthesis inhib-
itors CPR and NAL (TMP behaves differently in this assay; see
below), compared to no change or even a decrease for antibi-
otics with other modes of action (Figure S4F).
In principle, the increased MIC for DNA synthesis inhibitors
could be an indirect effect caused by the lower growth rate of
the mutants with rrn operon deletions. To discriminate between
such general growth rate effects and the specific effect of modi-
fied ribosomal expression in the rrn deletion strains, we reduced
the growth rate of the wild-type by changing the carbon source in
the growth medium, and asked if this change has a similar effect
on the MIC as the rrn operon deletions (Experimental Proce-
dures). We found that changing the growth rate in this way
does not lead to a detectable change in MIC for CPR and NAL,
but TMP shows a two-fold lower MIC when growth rate is
reduced to a level comparable to that of the D6 mutant (data
not shown). This allows us to rationalize the observation that,
unlike the case for CPR and NAL, the MIC for TMP is not
increased in the D6 strain (Figure S4F): the increased MIC due
to the reduction in ribosomal synthesis may be masked by the
reduction in MIC caused by the decreased growth rate. Overall,
our results show that strains with genetically reduced ribosome
synthesis survive better in the presence of DNA synthesisSPR conc. (MIC)
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Figure 4. Upregulation of Ribosomal Promoters by Protein Synthesis Inhibitors Is Delayed under DNA Stress
(A) Color map of normalized expression level 3rpmE of ribosomal promoter rpmE in a two-dimensional concentration matrix (black dots) of DNA synthesis inhibitor
(TMP) and translation inhibitor (SPR). Other ribosomal promoters behave similarly, Figure S3. Dashed line, line of constant growth rate (isobole; g = 0.38).
(B) Relative change in expression level 3rpmE(SPR) / 3rpmE(SPR = 0) as a function of SPR concentration, at no TMP (TMP = 0, gray), and at a fixed TMP concen-
tration (TMP = 0.34 MIC, magenta). Upregulation requires higher SPR concentration in the presence of TMP (arrow). Error-bars in (B) were estimated from the
standard deviation of replicate measurements done on different days (see Figure S17).
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Figure 5. Wild-Type Regulation of Ribosomal Expression Level under DNA Stress Is Nonoptimal: Genetically Manipulating Ribosome
Synthesis Can Increase Survival and Growth
(A) Normalized growth rates of wild-type (WT) and strains with incremental deletions of one to six of the seven rrn operons as well as forDrelA DspoT strain, in rich
medium (LB) in the absence (black) and presence of the DNA synthesis inhibitor CPR (red). Lines, 4th order polynomial fit to guide the eye. Schematic on left: strain
D5 in which 5 of 7 rrn operons are deleted. Schematic on right:DrelADspoT strain which is devoid of ppGpp, a key negative regulator of ribosome synthesis, while
other factors regulating ribosome synthesis remain. While wild-type expression level is optimized for maximal growth under no drug conditions, it is not optimized
for maximal growth under DNA synthesis inhibition: Reduced ribosome synthesis in rrn deletion strains increases growth.
(B) Sample data showing the growth curves (OD versus time) for WT (solid line) and D5 strain (dashed line) in no drug or under CPR at the concentration of (A).inhibitors, and thus that the wild-type regulation of ribosome
synthesis is nonoptimal for growth in these conditions.
Reducing Ribosome Synthesis Removes
the Suppressive Drug Interactions between DNA
Synthesis Inhibitors and Translation Inhibitors
If nonoptimality in the regulation of ribosome synthesis under
DNA stress is the cause for the suppressive interactions between
inhibitors of DNA synthesis and translation (Figure 1), then these
suppressive drug interactions should disappear in the geneti-
cally altered strains. To test this prediction, we measured growth
rates of the wild-type and the strains with genetically altered
ribosome expression levels in a two-dimensional drug matrix of
a DNA synthesis and a translation inhibitor (Experimental Proce-
dures). Strikingly, we find that genetically reducing ribosome
synthesis reduces the magnitude of the suppressive drug inter-
action and can even remove it entirely. Indeed, in contrast to
the wild-type, the D6 strain shows an almost additive interaction
(linear MIC line in Figure 6A compared to nonmonotonic line in
6B; see also definition of drug interactions in Figure 1A). We
observed this phenomenon for different antibiotic pairs that
inhibit DNA synthesis and translation, for differently constructedrrn deletion strains (Figure S12), and for strains grown in both rich
and minimal growth medium (Figures 6A, 6B, and S1). Further,
complementing the deletion strains with a plasmid expressing
one of the rrn operons (rrnB), partially restores the suppressive
interaction between the drugs (Figure S14). Together, these
results support the notion that the suppressive drug interaction
is caused by nonoptimal regulation of ribosome synthesis: the
reduced ribosome synthesis rate in the D6 strain is closer to
the optimal level for maximal growth rate under DNA stress
and, consequently, the addition of an antibiotic that inhibits
translation no longer has a beneficial effect.
Conversely, we tested whether impairing the downregulation
of ribosome synthesis can amplify suppressive drug interac-
tions. We can force ribosome synthesis in the presence of
TMP even further above its optimal level by using a relA spoT
deletion mutant. In this ppGpp-deficient mutant, the downregu-
lation of ribosome synthesis in response to TMP is impaired
since it cannot elicit the wild-type upregulation of ppGpp in
response to TMP (Khan and Yamazaki, 1972; Smith and Midgley,
1973). Indeed, we found that the impaired regulation of ribosome
synthesis in a relA spoT deletion mutant amplifies the suppres-
sive drug interaction between the DNA synthesis inhibitor TMPCell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc. 713
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Figure 6. Genetically Optimizing Ribosome Synthesis Removes Suppressive Drug Interaction between Inhibitors of DNA Synthesis and
Translation
Growth rates (gray levels) and MIC line (magenta) of D6 (A), WT (B), and DrelA DspoT strain (C) in two-dimensional concentration matrices (black dots) of DNA
synthesis inhibitor (TMP) and translation inhibitor (SPR). The suppressive drug interaction (B) disappears when ribosome synthesis is reduced (A) and is amplified
when downregulation of ribosome synthesis is impaired (C). The disappearance of suppression is incremental with number of rrn deletions and does not depend
on the specific DNA synthesis or translation inhibitor used, Figure S1. (D) Quantified level of suppression in the three strains. The level of suppression S is defined
as S = (MICmax - MIC0)/ MIC0, where MICmax is the maximal TMP MIC over all SPR concentrations and MIC0 the TMP MIC in absence of SPR. Cultures grown in
rich medium (LB).and the translation inhibitor SPR (compare Figure 6C to 6B). A
very similar effect is observed in a relA deletion mutant (Fig-
ure S7). The observation that increasing ribosomal expression
amplifies suppression while decreasing ribosomal expression
reduces it (Figure 6D) provides persuasive evidence that this
drug interaction is due to nonoptimal regulation of ribosome
expression.
A Simple Mathematical Model of Ribosome Synthesis
Regulation Captures Nonoptimal Response to DNA
Stress and Suppressive Drug Interactions
Why is ribosome synthesis so inappropriately regulated in
response to DNA synthesis inhibitors? To explore this issue, we
developed a coarse-grained mathematical model of ribosome
synthesis regulation in bacterial growth (Figure 7A and Supple-
mental Data). This model describes the interdependencies of the
cellular concentrations of DNA, proteins, ribosomes, resources,
and cellular growth at steady state. Resources enter the cell at
a fixed rate and are distributed between the production of
proteins, ribosomes and DNA. In the model, ribosome synthesis714 Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc.is regulated based on the intracellular concentration of these
resources. We optimize this regulation function to maximize the
growth rate at different resource uptake rates, corresponding to
different nutrient environments in the absence of antibiotics.
We then assume that this same regulation function based on
intracellular resource concentrations also applies when antibi-
otics are present. The effect of antibiotics is modeled as a reduc-
tion in the rate of translation or DNA synthesis. We further assume
that a threshold amount of protein per replication origin must be
produced to initiate DNA replication and cell division (Donachie,
1968; Donachie and Blakely, 2003). For simplicity, we assume
in the model that the cellular protein concentration is constant
so that the cell size is proportional to the total amount of protein
per cell (this approximation may not be true in general). Impor-
tantly, most parameters that enter into the model are known or
fully constrained by experimental data (Bremer and Dennis,
1996; Table S3). This simple model quantitatively reproduces
the changes in cell composition and growth rate that have been
observed in different nutrient environments (Bremer and Dennis,
1996; Figure S6).
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Figure 7. Mathematical Model with Optimal Growth Rate-Dependent Regulation of Ribosome Synthesis Yields Nonoptimal Response to
DNA Synthesis and Thereby Suppression by Translation Inhibitors
(A) Schematic depiction of a very simplified model of bacterial growth capturing resource allocation to DNA, ribosomes and proteins. Ribosome synthesis is
assumed to be optimally regulated by resource concentration. See Supplemental Data for the complete mathematical model.
(B) Growth rate obtained from the model for WT, rrn operon deletions and relA spoT deletions in the absence of antibiotics (black line) and in the presence of DNA
synthesis inhibitor (red line), cf. Figure 5A.
(C) Change of total protein per cell under translation inhibition (blue) or DNA synthesis inhibition (red), cf. Figure 2C. Inset shows total protein per cell at g = 0.15.
(D) Normalized ribosomal expression level 3ribos (corresponds to ribosomal protein fraction h in the model, see Supplemental Data) as a function of growth rate
under reduced nutrient availability (gray), translation inhibition (blue), or DNA synthesis inhibition (red). Ribosome synthesis is similarly downregulated in response
to reduced nutrient availability or DNA synthesis inhibition and is upregulated in response to translation inhibition, cf. Figure 3D.
(E) Quantified level of suppression in the different strains, cf. Figure 6D. Parameters as in Table S3 with resource influx na = 15 h
-1 which leads to a growth rate
g = 1.3 h-1 in absence of antibiotics, for details see Supplemental Data.The model and its resource-based optimization of ribosome
production faithfully describes our key experimental observa-
tions and in particular leads to nonoptimal regulation under
DNA stress. Specifically, it correctly captures the up- and down-
regulation of ribosome synthesis in the presence of translation
and DNA synthesis inhibitors, respectively (cf. Figures 3D and
7D). As in our experimental results, this reduction in the level of
ribosomal synthesis under DNA synthesis inhibition is similar to
the reduction seen when growth is attenuated by nutrient depri-
vation (red versus gray lines in Figure 7D; compare to experi-
ments in Figure 3D). This reduction in expression of ribosomal
synthesis is insufficient, leading to a skewed protein-DNA ratio
(cf. Figures 2 and 7C) and to sub-maximal growth rate (cf.
Figures 5A and 7B). Importantly, this simple model also repro-
duces the suppressive drug interaction between DNA synthesis
and translation inhibitors, its attenuation as a result of rrn operon
deletions, and its amplification as a result of relA spoT deletions
(cf. Figures 6D and 7E).DISCUSSION
We showed that ribosome synthesis is not specifically regulated
by DNA synthesis inhibiting drugs, leading to a skewed DNA to
protein ratio and sub-maximal growth rate. Genetically reducing
ribosome synthesis allows cells to grow faster under DNA stress.
Importantly, this genetic optimization of ribosome synthesis also
eliminates the suppressive drug interactions between protein
and DNA synthesis inhibitors. A simple mathematical model
proposes that optimal regulation of ribosome production based
on intracellular resource concentrations in normal conditions
can lead to nonoptimal resource allocation between DNA and
protein synthesis under DNA synthesis inhibition, and thereby
to decreased growth. This explanation, while fully consistent
with our data, does not exclude the possibility that other mech-
anisms contribute to the suppressive interactions between
DNA synthesis inhibitors and translation inhibitors. For example,
reduced protein synthesis leads to reduced growth rate andCell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc. 715
thereby to a smaller number of replication forks, which ultimately
may reduce the impact of DNA synthesis inhibitors, especially
of gyrase inhibitors which cause double strand breaks and
cell death through oxidative stress (Dwyer et al., 2007; Kolod-
kin-Gal et al., 2008). Upregulation of drug efflux pumps may
also play a role (Poole, 2005).
Our result that regulation of ribosomal gene expression in
response to sustained DNA stress is not optimal for maximal
growth in laboratory conditions raises the question of whether
this response might be optimized for another goal or for other
more natural conditions. The lack of specific regulation of
ribosomal genes under DNA stress is particularly puzzling
given E. coli’s ability to specifically regulate genes through
the SOS response (Friedman et al., 2005; Michel, 2005; Rad-
man, 1975; Tippin et al., 2004). There are several ways in which
the observed lack of specific response to DNA stress could
actually be beneficial in natural conditions. First, it is possible
that in the natural environment in which the organism evolved,
DNA synthesis inhibition is usually encountered at the same
time as nutrient deprivation, removing the need for a specific
mechanism to downregulate protein synthesis (Cashel et al.,
1996; Gralla, 2005; Paul et al., 2004). Indeed, gene regulation
responses can exploit correlations between environmental
changes, even if they do not occur simultaneously (Mitchell
et al., 2009; Tagkopoulos et al., 2008). Second, it is possible
that DNA stress is usually short-lived in the natural environment,
and so the global response to DNA damage and the formation
of larger, filamentous cells could be optimized to ensure a
fast recovery when the stress is relieved (Guan and Burnham,
1992). Finally, it is possible that phenotypic variability between
cells, which increases under DNA stress (Figure 2A,B), plays
a role in the survival strategy under these conditions (Balaban
et al., 2004; Guido et al., 2007; Kussell and Leibler, 2005;
Pearl et al., 2008). In any case, while the lack of specific regu-
lation of ribosomal genes under DNA stress could be optimal in
some conditions, it is clearly nonoptimal in the laboratory
condition.
In summary, we showed that nonoptimal regulation of
ribosome synthesis is at the heart of the suppressive drug
interactions between protein and DNA synthesis inhibitors.
Understanding the underlying mechanism of the interaction
allowed us to genetically manipulate whether and to what extent
these two drug classes interact. More generally, these results
show that cellular systems, even those critical for growth and
survival, are not always optimally regulated, and that tight
optimal control in some conditions can lead to nonoptimal regu-
lation in other conditions. Such nonoptimal regulation may open
possibilities for new ways to manipulate cellular growth in the lab
and in the clinic.
EXPERIMENTAL PROCEDURES
Media, Strains, and Drugs
Experiments were conducted as indicated in rich Luria-Bertani (LB) broth or
M9 minimal medium with different carbon sources (glucose, galactose,
glycerol) at 0.4%. Glucose M9 was supplemented with 0.2% amicase. Drug
solutions were made from powder stocks, filter-sterilized, stored at 20C in
the dark and added as indicated. All strains used were derived from E. coli
K-12 strain MG1655 (Supplemental Data and Table S2).716 Cell 139, 707–718, November 13, 2009 ª2009 Elsevier Inc.Growth Rate and MIC Assays
Overnight cultures were diluted 2000-fold and grown on an automated
robotic system (Caliper) at 30C with rapid shaking in 96-well microtiter plates
(Costar) containing 200 ml medium per well. Absorbance at 600nm (A600,
proportional to optical density OD600, proportionality constant 3.1) and GFP
fluorescence were recorded by a plate reader (Victor III or EnVision, Perkin-
Elmer) at intervals of 30 min for at least 24 hr, and background subtracted.
Growth rates were calculated using Matlab by linear regression of log(OD600)
(Matlab function ‘‘regress’’) during exponential growth (0.01 < A600 < 0.1).
The measurement error was evaluated as the 95% confidence interval of the
linear regression (error bars in Figure 5A). Growth was annotated as no data
if the regression error was greater than 20%. Also removed are some cases
where resistant mutants occurred, in particular for CPR and NAL; these
were identified by large variations between replicates and by no growth for
12 hr or longer followed by fast growth. Two-dimensional drug concentration
matrices were set up on one 96-well plate (11 3 8 format) or on four plates
(22 3 16 format) leaving one column per plate for controls. To reduce noise,
a smoothed function was fitted to the measured growth rates by using a
smoothing cubic spline, and linearly interpolated isoboles were plotted (Matlab
functions ‘‘csaps’’ and ‘‘contour’’).
MIC was defined as the lowest concentration at which background sub-
tracted A600 did not exceed 0.02 after 24 hr. MICs were first determined
crudely in logarithmic antibiotic concentration gradients with two-fold dilutions
and then more accurately with linear gradients ranging from zero to about two
times the MIC.
Gene Expression Assay
GFP reporter strains were grown in glucose M9 medium supplemented with
0.2% amicase. GFP background was subtracted as described (Zaslaver
et al., 2006). We defined the expression level as the mean GFP/A600 in the
interval 0.04 < A600 < 0.3, Figure 3A. Only promoters with a clearly detectable
GFP signal were used for analysis, reducing the total number to 110 promoters,
Figure 3B. Expression level changes g relative to the drug-free control were
normalized to the median expression level change <g> of all promoters in the
same drug environment. Changes in the median expression level of all
promoters reflect nonspecific effects such as pH changes or changes of the
reporter plasmid copy number. We verified that the effect of plasmid copy
number on the measured expression level is independent of the GFP promoter,
by comparing to strains in which the same GFP reporters were integrated into
the chromosome (Supplemental Data).
DNA and Protein Assay
Cultures were grown to OD6000.2 in glucose M9 medium, DAPI stained
(5 mg/ml, 5 min), mounted on agar pads, and imaged (Figure 2A). Cell
lengths were measured manually using ImageJ (http://rsbweb.nih.gov/ij/) for
100 cells in each condition (Figure 2B). To calculate protein per cell, we
combined 8 identical 200 ml cultures and determined the total protein concen-
tration using the DC protein assay (Biorad). Cell concentration was estimated
by colony plate count. We slightly over-estimate protein per cell because cells
devoid of DNA (less than 10% of cells) do not form colonies. Error bars in
Figure 2C represent the error N1/2 for the cell count N.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, three
tables, and seventeen figures and can be found with this article online at
http://www.cell.com/supplemental/S0092-8674(09)01315-4.
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